Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis.
暂无分享,去创建一个
J. Banchereau | P. Delmas | J. Déchanet | J. Moreau | P. Miossec | P. Chomarat | J. Roux | J. Moreau | P. Delmas | J. Déchanet
[1] J. Banchereau,et al. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. , 1993, Journal of immunology.
[2] S. Wahl,et al. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. , 1993, Journal of immunology.
[3] N. Gualde,et al. Immunogenicity of HILDA/LIF either in a Soluble or in a Membrane Anchored Form expressed In Vivo by Recombinant Vaccinia Viruses , 1993, Scandinavian journal of immunology.
[4] P. Delmas,et al. Immunoassay of pyridinoline crosslink excretion in normal adults and in paget's disease , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] M. Horowitz. Cytokines and estrogen in bone: anti-osteoporotic effects. , 1993, Science.
[6] T. Miyamoto,et al. Interleukin-4 enhances in vitro mineralization in human osteoblast-like cells. , 1992, Biochemical and biophysical research communications.
[7] H. Katai,et al. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. , 1992, The Journal of clinical investigation.
[8] P. Villiger,et al. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. , 1992, The Journal of clinical investigation.
[9] J. Banchereau,et al. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. , 1992, Arthritis and rheumatism.
[10] H. Broxmeyer,et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6 , 1992 .
[11] M. Gowen,et al. Cytokines and bone. , 1992, British journal of rheumatology.
[12] B. Klein,et al. Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies. , 1991, Molecular immunology.
[13] D. Lacey,et al. Interleukin 4 inhibits murine osteoclast formation in vitro , 1991, Journal of cellular biochemistry.
[14] C. Christiansen,et al. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. , 1991, The Journal of clinical endocrinology and metabolism.
[15] J. Banchereau,et al. Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. , 2010, Arthritis and rheumatism.
[16] K. Watanabe,et al. Interleukin-4 as a potent inhibitor of bone resorption. , 1990, Biochemical and biophysical research communications.
[17] P. Miossec,et al. Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid. , 1990, Arthritis and rheumatism.
[18] F. Epstein,et al. Rheumatoid arthritis. Pathophysiology and implications for therapy. , 1990, The New England journal of medicine.
[19] R. Maki,et al. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. , 1990, Journal of immunology.
[20] I. Reid,et al. Leukemia Inhibitory Factor: A Novel Bone-Active Cytokine* , 1990 .
[21] M. Ziff. Rheumatoid arthritis--its present and future. , 1990, The Journal of rheumatology.
[22] L. Avioli,et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Guerne,et al. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. , 1989, The Journal of clinical investigation.
[24] Y. Takebe,et al. Isolation and characterization of multiple variants of recombinant human interleukin 4 expressed in mammalian cells. , 1988, The Journal of biological chemistry.
[25] D. Heinegård,et al. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. , 1988, Arthritis and rheumatism.
[26] N. Miyasaka,et al. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. , 1988, Arthritis and rheumatism.
[27] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[28] B Henderson,et al. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Dinarello,et al. Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. , 1986, Arthritis and rheumatism.
[30] T. Bringman,et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.
[31] R. Russell,et al. An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.
[32] M. Kurosaka,et al. Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium , 1983, The Journal of experimental medicine.
[33] C. Dinarello,et al. Isolation of an interleukin-1-like factor from human joint effusions. , 1983, Arthritis and rheumatism.
[34] R. Winchester,et al. Identification of Three Major Synovial Lining Cell Populations by Monoclonal Antibodies Directed to Ia Antigens and Antigens Associated with Monocytes/Macrophages and Fibroblasts , 1983, Scandinavian journal of immunology.